Biogen, Denali Therapeutics To Collaborate On LRRK2 Program For Parkinson's Disease, Certain TV Platform-Enabled Programs For Neurodegenerative Diseases; Denali To Receive $560M Upfront Payment, $465M Equity Investment, Potential Milestone Payments